PBYI logo

Puma Biotechnology (PBYI) Net Income

Annual Net Income

$30.28 M
+$8.69 M+40.23%

December 31, 2024

Summary

Performance

1-Year Change

+40.23%

3-Year Change

+203.96%

5-Year Change

+140.05%

15-Year Change

+110.37%

PBYI Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

87.78%
PBYI annual net profit is higher than 87.78% of companies in Healthcare sector

High & Low

All-time High

$30.28 M
PBYI annual net profit is currently at an all-time high

3-Year Low

-$29.13 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2024
PBYI previous annual earnings announcement was published on Dec 31, 2024

Next Annual Earnings Report Date

N/A
PBYI next annual earnings announcement has not yet been scheduled

OtherPBYIprofitabilitymetrics:

Annual Net Margin

-
PBYI annual net profit margin value is unknown

Annual Revenue

$230.47 M
PBYI annual revenue is $230.47 million

Annual Gross Profit

$166.06 M
PBYI annual gross profit is $166.06 million

Annual EPS

-
PBYI annual earnings per share value is unknown

Quarterly Net Income

$19.30 M
-$1.01 M-4.98%

December 31, 2024

Summary

Performance

3-Month Change

-4.98%

1-Year Change

-4.98%

3-Year Change

+106.01%

5-Year Change

+106.01%

PBYI Quarterly Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

88.41%
PBYI quarterly net profit is higher than 88.41% of companies in Healthcare sector

High & Low

All-time High

$20.32 M
PBYI quarterly net profit is currently -4.98% below its historical high of $20.32 million

3-Year Low

-$5.61 M

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2024
PBYI previous earnings announcement was published on Dec 31, 2024

Next Quarterly Earnings Report Date

May 2, 2025
PBYI next earnings announcement is scheduled for May 2, 2025

OtherPBYIprofitabilitymetrics:

Quarterly Net Margin

-
PBYI quarterly net profit margin value is unknown

Quarterly Revenue

$59.08 M
PBYI quarterly revenue is $59.08 million

Quarterly Gross Profit

$45.16 M
PBYI quarterly gross profit is $45.16 million

Quarterly EPS

$0.39
PBYI quarterly earnings per share is $0.39

TTM Net Income

$30.28 M
+$7.04 M+30.28%

December 31, 2024

Summary

Performance

3-Month Change

+30.28%

1-Year Change

+30.28%

3-Year Change

+187.81%

5-Year Change

+187.81%

PBYI TTM Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

87.55%
PBYI TTM net profit is higher than 87.55% of companies in Healthcare sector

High & Low

All-time High

$30.28 M
PBYI TTM net profit is currently at an all-time high

3-Year Low

-$48.96 M

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2024
PBYI previous earnings announcement was published on Dec 31, 2024

Next Quarterly Earnings Report Date

May 2, 2025
PBYI next earnings announcement is scheduled for May 2, 2025

OtherPBYIprofitabilitymetrics:

Annual Net Margin

-
PBYI annual net profit margin value is unknown

TTM Revenue

$230.47 M
PBYI TTM revenue is $230.47 million

TTM Gross Profit

$166.06 M
PBYI TTM gross profit is $166.06 million

TTM EPS

$0.61
PBYI TTM earnings per share is $0.61

Net Income Formula

Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses

Annual Net Income

$30.28 M
PBYI annual net profit is $30.28 million

Annual Revenue

$230.47 M
PBYI annual revenue is $230.47 million

Annual Cost Of Goods Sold

$64.40 M
PBYI annual cost of goods sold is $64.40 million

Annual Operating Expenses

$135.10 M
PBYI annual total operating expenses is $135.10 million

Annual Interest Expense

$12.45 M
PBYI annual interest expense is $12.45 million

Annual Income Tax

-$6.18 M
PBYI annual income tax is -$6.18 million

PBYI Net Income Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+40.2%-5.0%+30.3%
3 y3 years+204.0%+106.0%+187.8%
5 y5 years+140.1%+106.0%+187.8%

PBYI Net Income Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+204.0%-5.0%+444.4%at high+161.8%
5 y5-yearat high+140.1%-5.0%+143.2%at high+136.7%
alltimeall timeat high+110.4%-5.0%+124.8%at high+110.1%

Puma Biotechnology Net Income History

DateAnnualQuarterlyTTM
Dec 2024
$30.28 M(+40.2%)
$19.30 M(-5.0%)
$30.28 M(+30.3%)
Sep 2024
-
$20.32 M(-548.6%)
$23.24 M(+166.5%)
Jun 2024
-
-$4.53 M(-5.9%)
$8.72 M(-43.3%)
Mar 2024
-
-$4.82 M(-139.2%)
$15.38 M(-28.8%)
Dec 2023
$21.59 M(>+9900.0%)
$12.27 M(+111.7%)
$21.59 M(+480.9%)
Sep 2023
-
$5.80 M(+172.6%)
$3.72 M(-252.4%)
Jun 2023
-
$2.13 M(+51.7%)
-$2.44 M(-150.7%)
Mar 2023
-
$1.40 M(-125.0%)
$4.81 M(>+9900.0%)
Dec 2022
$2000.00(-100.0%)
-$5.61 M(+1457.2%)
$2000.00(-100.0%)
Sep 2022
-
-$360.00 K(-103.8%)
$9.83 M(-128.5%)
Jun 2022
-
$9.37 M(-375.4%)
-$34.48 M(-29.6%)
Mar 2022
-
-$3.40 M(-180.6%)
-$48.96 M(+68.7%)
Dec 2021
-$29.13 M(-51.5%)
$4.22 M(-109.5%)
-$29.03 M(-39.8%)
Sep 2021
-
-$44.67 M(+774.9%)
-$48.24 M(+37.7%)
Jun 2021
-
-$5.11 M(-130.9%)
-$35.03 M(+32.0%)
Mar 2021
-
$16.53 M(-210.2%)
-$26.53 M(-55.8%)
Dec 2020
-$59.99 M(-20.6%)
-$14.99 M(-52.3%)
-$59.99 M(+6.8%)
Sep 2020
-
-$31.46 M(-1026.7%)
-$56.20 M(+35.0%)
Jun 2020
-
$3.40 M(-120.0%)
-$41.62 M(-49.5%)
Mar 2020
-
-$16.93 M(+51.2%)
-$82.44 M(+9.1%)
Dec 2019
-$75.59 M(-33.4%)
-$11.20 M(-33.7%)
-$75.59 M(-20.5%)
Sep 2019
-
-$16.89 M(-54.9%)
-$95.09 M(+2.9%)
Jun 2019
-
-$37.42 M(+271.0%)
-$92.41 M(-7.0%)
Mar 2019
-
-$10.09 M(-67.1%)
-$99.32 M(-12.6%)
Dec 2018
-$113.58 M(-61.1%)
-$30.70 M(+116.1%)
-$113.58 M(-22.7%)
Sep 2018
-
-$14.20 M(-68.0%)
-$146.96 M(-30.0%)
Jun 2018
-
-$44.34 M(+82.1%)
-$209.94 M(-13.8%)
Mar 2018
-
-$24.34 M(-62.0%)
-$243.44 M(-16.6%)
Dec 2017
-$291.95 M(+5.8%)
-$64.08 M(-17.0%)
-$291.95 M(-2.9%)
Sep 2017
-
-$77.18 M(-0.8%)
-$300.54 M(+3.9%)
Jun 2017
-
-$77.83 M(+6.8%)
-$289.14 M(+4.0%)
Mar 2017
-
-$72.86 M(+0.3%)
-$277.90 M(+0.7%)
Dec 2016
-$276.01 M
-$72.66 M(+10.5%)
-$276.01 M(+4.1%)
Sep 2016
-
-$65.78 M(-1.2%)
-$265.07 M(+2.1%)
DateAnnualQuarterlyTTM
Jun 2016
-
-$66.60 M(-6.2%)
-$259.70 M(+0.7%)
Mar 2016
-
-$70.97 M(+15.0%)
-$257.80 M(+7.7%)
Dec 2015
-$239.28 M(+68.6%)
-$61.72 M(+2.2%)
-$239.28 M(+6.3%)
Sep 2015
-
-$60.42 M(-6.6%)
-$225.05 M(+12.3%)
Jun 2015
-
-$64.69 M(+23.3%)
-$200.47 M(+14.8%)
Mar 2015
-
-$52.45 M(+10.5%)
-$174.63 M(+23.0%)
Dec 2014
-$141.97 M(+159.7%)
-$47.48 M(+32.5%)
-$141.97 M(+28.6%)
Sep 2014
-
-$35.84 M(-7.7%)
-$110.43 M(+24.3%)
Jun 2014
-
-$38.84 M(+96.2%)
-$88.87 M(+41.8%)
Mar 2014
-
-$19.79 M(+24.1%)
-$62.67 M(+14.7%)
Dec 2013
-$54.66 M(-26.5%)
-$15.95 M(+11.6%)
-$54.66 M(-9.8%)
Sep 2013
-
-$14.28 M(+12.9%)
-$60.63 M(-16.0%)
Jun 2013
-
-$12.65 M(+7.4%)
-$72.20 M(-2.8%)
Mar 2013
-
-$11.78 M(-46.2%)
-$74.31 M(-0.1%)
Dec 2012
-$74.35 M(+626.6%)
-$21.91 M(-15.3%)
-$74.35 M(+19.4%)
Sep 2012
-
-$25.86 M(+75.3%)
-$62.29 M(+69.4%)
Jun 2012
-
-$14.75 M(+24.8%)
-$36.77 M(+66.7%)
Mar 2012
-
-$11.83 M(+20.1%)
-$22.06 M(+115.5%)
Dec 2011
-$10.23 M(>+9900.0%)
-$9.85 M(+2734.6%)
-$10.23 M(+2576.7%)
Sep 2011
-
-$347.40 K(+912.8%)
-$382.30 K(+903.4%)
Jun 2011
-
-$34.30 K(+779.5%)
-$38.10 K(+514.5%)
Mar 2011
-
-$3900.00(-218.2%)
-$6200.00(-11.4%)
Dec 2010
-$7000.00(-58.3%)
$3300.00(-203.1%)
-$7000.00(-48.5%)
Sep 2010
-
-$3200.00(+33.3%)
-$13.60 K(-0.7%)
Jun 2010
-
-$2400.00(-48.9%)
-$13.70 K(-11.6%)
Mar 2010
-
-$4700.00(+42.4%)
-$15.50 K(-7.7%)
Dec 2009
-$16.80 K(+19.1%)
-$3300.00(0.0%)
-$16.80 K(+7.0%)
Sep 2009
-
-$3300.00(-21.4%)
-$15.70 K(-4.3%)
Jun 2009
-
-$4200.00(-30.0%)
-$16.40 K(+5.1%)
Mar 2009
-
-$6000.00(+172.7%)
-$15.60 K(+10.6%)
Dec 2008
-$14.10 K
-$2200.00(-45.0%)
-$14.10 K(+18.5%)
Sep 2008
-
-$4000.00(+17.6%)
-$11.90 K(+50.6%)
Jun 2008
-
-$3400.00(-24.4%)
-$7900.00(+75.6%)
Mar 2008
-
-$4500.00
-$4500.00

FAQ

  • What is Puma Biotechnology annual net profit?
  • What is the all time high annual net income for Puma Biotechnology?
  • What is Puma Biotechnology annual net income year-on-year change?
  • What is Puma Biotechnology quarterly net profit?
  • What is the all time high quarterly net income for Puma Biotechnology?
  • What is Puma Biotechnology quarterly net income year-on-year change?
  • What is Puma Biotechnology TTM net profit?
  • What is the all time high TTM net income for Puma Biotechnology?
  • What is Puma Biotechnology TTM net income year-on-year change?

What is Puma Biotechnology annual net profit?

The current annual net income of PBYI is $30.28 M

What is the all time high annual net income for Puma Biotechnology?

Puma Biotechnology all-time high annual net profit is $30.28 M

What is Puma Biotechnology annual net income year-on-year change?

Over the past year, PBYI annual net profit has changed by +$8.69 M (+40.23%)

What is Puma Biotechnology quarterly net profit?

The current quarterly net income of PBYI is $19.30 M

What is the all time high quarterly net income for Puma Biotechnology?

Puma Biotechnology all-time high quarterly net profit is $20.32 M

What is Puma Biotechnology quarterly net income year-on-year change?

Over the past year, PBYI quarterly net profit has changed by -$1.01 M (-4.98%)

What is Puma Biotechnology TTM net profit?

The current TTM net income of PBYI is $30.28 M

What is the all time high TTM net income for Puma Biotechnology?

Puma Biotechnology all-time high TTM net profit is $30.28 M

What is Puma Biotechnology TTM net income year-on-year change?

Over the past year, PBYI TTM net profit has changed by +$7.04 M (+30.28%)